Our investigation found that ACTA2, FLNA, TAGLN, and TPM1 substantially downregulated in BLCA samples compared to normal samples, independent of gender, race, or smoking behavior. This evidence concerns the gene ACTA2 and bladder transitional cell carcinoma.